Cargando…

Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer

BACKGROUND: We aimed to analyze the frequency and distribution of PD-L1 expression in specimens from prostate cancer (PC) patients using two different anti-PD-L1 antibodies (E1L3N, SP263). MATERIALS AND METHODS: PD-L1 immunohistochemistry was performed in a tissue microarray consisting of 82 castrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fankhauser, Christian D., Schüffler, Peter J., Gillessen, Silke, Omlin, Aurelius, Rupp, Niels J., Rueschoff, Jan H., Hermanns, Thomas, Poyet, Cedric, Sulser, Tullio, Moch, Holger, Wild, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828186/ https://www.ncbi.nlm.nih.gov/pubmed/29535806 http://dx.doi.org/10.18632/oncotarget.22888

Ejemplares similares

Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer
por: Rupp, Niels J., et al.
Publicado: (2016)

Effectiveness of Flexible Ureterorenoscopy Versus Extracorporeal Shock Wave Lithotripsy for Renal Calculi of 5–15 mm: Results of a Randomized Controlled Trial
por: Fankhauser, Christian Daniel, et al.
Publicado: (2021)

Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death
por: Mortezavi, Ashkan, et al.
Publicado: (2017)

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer
por: Poyet, Cédric, et al.
Publicado: (2014)

Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer
por: Poyet, Cédric, et al.
Publicado: (2015)

Therapy-resistant nephrolithiasis following renal artery coil embolization
por: Poyet, Cédric, et al.
Publicado: (2013)

CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer
por: Wettstein, Marian S., et al.
Publicado: (2015)

Prevalence of hypertension and diabetes after exposure to extracorporeal shock-wave lithotripsy in patients with renal calculi: a retrospective non-randomized data analysis
por: Fankhauser, Christian Daniel, et al.
Publicado: (2018)

Extracorporeal shock wave lithotripsy versus flexible ureterorenoscopy in the treatment of untreated renal calculi
por: Fankhauser, Christian D, et al.
Publicado: (2018)

Correction to: Prevalence of hypertension and diabetes after exposure to extracorporeal shock-wave lithotripsy in patients with renal calculi: a retrospective non-randomized data analysis
por: Fankhauser, Christian Daniel, et al.
Publicado: (2018)

Extracorporeal shock wave lithotripsy versus flexible ureterorenoscopy in the treatment of untreated renal calculi
por: Fankhauser, Christian D, et al.
Publicado: (2018)

Retroperitoneal teratoma with somatic malignant transformation: A papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy
por: Zeh, Nina, et al.
Publicado: (2013)

In-depth Analysis of the 2019 Advanced Prostate Cancer Consensus Conference: The Importance of Representation of Medical Specialty and Geographic Regions
por: Pratsinis, Manolis, et al.
Publicado: (2021)

Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer
por: Goetze, Sandra, et al.
Publicado: (2022)

Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer
por: De Vargas Roditi, Laura, et al.
Publicado: (2022)

A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients
por: Zhong, Qing, et al.
Publicado: (2017)

Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer
por: POYET, CÉDRIC, et al.
Publicado: (2015)

The Role of Additional Epididymis Resection during Hydrocelectomy: Is It of Any Benefit in Comparison to Simple Hydrocelectomy?
por: Grossmann, Nico C., et al.
Publicado: (2023)

CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors
por: Fankhauser, Christian Daniel, et al.
Publicado: (2019)

Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers
por: Guo, Tiannan, et al.
Publicado: (2018)

High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer
por: Benoit, Tobias, et al.
Publicado: (2015)

Treatment sequencing in metastatic castrate-resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2014)

Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity
por: Zhong, Qing, et al.
Publicado: (2016)

Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer—what has gone wrong? A blueprint for the way forward in biomarker studies
por: Huber, F, et al.
Publicado: (2015)

Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16)
por: Gillessen, Silke, et al.
Publicado: (2023)

Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy
por: Fankhauser, Christian Daniel, et al.
Publicado: (2018)

Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data
por: Grogg, Josias Bastian, et al.
Publicado: (2020)

Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer
por: Endt, Kathrin, et al.
Publicado: (2017)

MAGE-C2/CT10 Protein Expression Is an Independent Predictor of Recurrence in Prostate Cancer
por: von Boehmer, Lotta, et al.
Publicado: (2011)

Oncological and functional outcomes after testis-sparing surgery in patients with germ cell tumors: a systematic review of 285 cases
por: Grogg, Josias Bastian, et al.
Publicado: (2022)

TMARKER: A free software toolkit for histopathological cell counting and staining estimation
por: Schüffler, Peter J., et al.
Publicado: (2013)

Prostate cancer detection rate in men undergoing transperineal template‐guided saturation and targeted prostate biopsy
por: Kaufmann, Basil, et al.
Publicado: (2021)

Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study
por: Bieri, Uwe, et al.
Publicado: (2022)

Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone
por: Lorente, D, et al.
Publicado: (2014)

Automated Gleason grading of prostate cancer tissue microarrays via deep learning
por: Arvaniti, Eirini, et al.
Publicado: (2018)

Author Correction: Automated Gleason grading of prostate cancer tissue microarrays via deep learning
por: Arvaniti, Eirini, et al.
Publicado: (2019)

Author Correction: Automated Gleason grading of prostate cancer tissue microarrays via deep learning
por: Arvaniti, Eirini, et al.
Publicado: (2021)

T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein
por: Laurent, Julien, et al.
Publicado: (2013)

Modified Immunoscore Improves Prediction of Survival Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer—A Retrospective Digital Pathology Study
por: Bieri, Uwe, et al.
Publicado: (2022)

Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence
por: Christiansen, Ailsa J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1jvtqj04qs4qssqfk2et45r9g5